| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016583A2 Constructs and their use in metabolic pathway engineering |
| 02/28/2002 | WO2002016581A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016580A2 Flow-through system for lysate clarification and nucleic acid binding in a single step |
| 02/28/2002 | WO2002016579A2 Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| 02/28/2002 | WO2002016578A2 Secreted proteins and methods of using same |
| 02/28/2002 | WO2002016577A2 Enhanced recovery of transformed cells |
| 02/28/2002 | WO2002016575A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 02/28/2002 | WO2002016572A2 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature |
| 02/28/2002 | WO2002016571A1 Magnetic particles having lower limit critical solution temperature |
| 02/28/2002 | WO2002016570A1 Dms:acceptor oxidoreductase |
| 02/28/2002 | WO2002016569A2 38618, a human alpha/beta hydrolase and uses thereof |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016566A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | WO2002016565A2 Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes |
| 02/28/2002 | WO2002016564A2 Novel human proteases and polynucleotides encoding the same |
| 02/28/2002 | WO2002016563A2 14189, a human kinase and uses thereof |
| 02/28/2002 | WO2002016562A2 22244 and 8701, novel human dehydrogenases and uses thereof |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016560A1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 02/28/2002 | WO2002016558A1 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016550A2 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 02/28/2002 | WO2002016549A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 02/28/2002 | WO2002016528A1 Magnetic particles and process for producing the same |
| 02/28/2002 | WO2002016440A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | WO2002016437A2 Rhabdovirus-based vectors to express high levels of functional human antibodies |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016435A2 Human 7tm proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016432A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016428A1 Irap-binding protein |
| 02/28/2002 | WO2002016426A2 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | WO2002016424A2 Dna binding peptide domains and a method for providing domains of this type |
| 02/28/2002 | WO2002016423A2 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS |
| 02/28/2002 | WO2002016422A2 Recombinant constructs of borrelia burgdorferi |
| 02/28/2002 | WO2002016421A2 Altered ospa of borrelia burgdorferi |
| 02/28/2002 | WO2002016420A2 Antiviral compounds derived from the hsv gd protein and methods |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016418A2 An iap binding peptide or polypeptide and methods of using the same |
| 02/28/2002 | WO2002016417A2 Transgenic animal model for neurodegerative disease and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002016397A2 Haplotypes of the lipg gene |
| 02/28/2002 | WO2002016396A2 Mammalian rh type b glycoprotein ion transporter |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002016383A1 Method for the isolation of nucleic acids and for quantitative dna extraction and detection for leukocyte evaluation in blood products |
| 02/28/2002 | WO2002016377A2 Human cytidine monophosphate (cmp) kinase cdna |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015931A1 Immunologic method for the prevention of dental caries |
| 02/28/2002 | WO2002015927A1 High mannose proteins and methods of making high mannose proteins |
| 02/28/2002 | WO2002015918A2 Method and compositions for promoting osteogenesis |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2002015701A2 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | WO2002015681A1 Transgenic mammals |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2002015675A1 Genes for modifying plant traits iv |
| 02/28/2002 | WO2002015674A1 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 02/28/2002 | WO2002010372A8 Method of producing functional protein domains |
| 02/28/2002 | WO2001085967A3 Corynebacterium glutamicum strain with enhanced secretion activity |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001083795A3 Particulate adenovirus, use thereof in vaccination |
| 02/28/2002 | WO2001083763A3 Phytase polypeptides |
| 02/28/2002 | WO2001083747A3 Prion proteins and their uses |
| 02/28/2002 | WO2001081609A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/28/2002 | WO2001081595A3 Human caspase-14 compositions |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001079441A3 Gene inactivation by targeted dna methylation |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001077377A8 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 02/28/2002 | WO2001077334A3 Lactococcus lactis genome, polypeptides and uses |
| 02/28/2002 | WO2001076636A3 Pharmaceutical composition of modified pna molecules |
| 02/28/2002 | WO2001075112A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001073083A3 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001072967A3 Promoter sequence of 3-phosphoglycerate kinase gene 2 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001071732B1 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 02/28/2002 | WO2001070997A3 Regulation of human leucine aminopeptidase-like enzyme |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001070947A3 Method for generating recombinant dna molecules in complex mixtures |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001068845A3 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 02/28/2002 | WO2001066150A9 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 02/28/2002 | WO2001064888A3 Kunitz domain polypeptide zkun8 |
| 02/28/2002 | WO2001064881A3 23927, a human ion channel |
| 02/28/2002 | WO2001064718A3 Human proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2001060998A3 Small oligonucleotides with anti-tumor activity |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001058938A3 Human neurexin-like proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2001058936A3 Constructs for delivery of therapeutic agents to neuronal cells |
| 02/28/2002 | WO2001057273A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |